Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
Also known as 17-alpha-hydroxylase/17,20-lyase deficiency, CAH due to 17-alpha-hydroxylase deficiency, combined 17-hydroxylase/17,20-lyase deficiency, 17,20-lyase deficiency, isolated+6 more
17-alpha-hydroxylase/17,20-lyase deficiency, CAH due to 17-alpha-hydroxylase deficiency, combined 17-hydroxylase/17,20-lyase deficiency, 17,20-lyase deficiency, isolated, 17-Alpha-Hydroxylase deficiency, 17-Alpha-Hydroxylase/17,20-lyase deficiency, combined complete, 17-Alpha-Hydroxylase/17,20-lyase deficiency, combined partial, adrenal hyperplasia 5, adrenal hyperplasia, congenital, due to 17-ALPHA-HYDROXYLASE deficiency, congenital adrenal hyperplasia type 5.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
17-alpha-hydroxylase/17,20-lyase deficiency, CAH due to 17-alpha-hydroxylase deficiency, combined 17-hydroxylase/17,20-lyase deficiency, 17,20-lyase deficiency, isolated, 17-Alpha-Hydroxylase deficiency, 17-Alpha-Hydroxylase/17,20-lyase deficiency, combined complete, 17-Alpha-Hydroxylase/17,20-lyase deficiency, combined partial, adrenal hyperplasia 5, adrenal hyperplasia, congenital, due to 17-ALPHA-HYDROXYLASE deficiency, congenital adrenal hyperplasia type 5
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Related entities are derived from literature co-mention (studied together) — associative, not causal.